In 2025, the drug racked up net sales of $68.2 million, up from $60.1 million in the previous year.\ Q4 Earnings In Q4 FY26, Zydus' revenue from operations increased by 16 per cent year-on-year (YoY) to Rs 7,587 crore, while net profit grew 14.6 per cent to Rs 1,592 crore
If cost is a barrier, PlexusDx offers semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan from licensed 503A compounding pharmacies, with no insurance required and HSA/FSA eligibility
All these disorders share the following pathophysiological features: amyloid accumulation, tau hyperphosphorylation, cerebral vasculopathy, inflammation, and oxidative stress in the CNS
Several reviews specifically note weekend responsiveness, with customer support answering emails and messages on Saturdays and Sundays when many competing platforms operate only during business hours
2023;47(1):19.38560360 [Google Scholar] 807
In concrete numbers, this means that 1 in 8 American adults has been estimated to have tried the drug to date